The Medicare Payment Advisory Commission today released its March report to Congress. The report details the fee-for-service payment recommendations for 2021 approved by the commission in January, including recommendations for hospital services and post-acute care. For hospital inpatient and outpatient prospective payment systems, MedPAC recommended that Congress provide a 2% market-basket update in 2021, using the difference between the update and amount specified in current law to increase hospital payments through its proposed Hospital Value Incentive Program. As expected, the report also includes a staff analysis of the relationship between the 340B drug savings program and oncology drug costs, requested by the House Energy and Commerce Committee in 2018. The findings were inconclusive overall, showing higher spending for some cancer drugs but not others, and not generalizable to other conditions. For more information, see the MedPAC factsheet.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services yesterday released a fact sheet for state and local governments seeking Medicare, Medicaid or Children’s…
Headline
Over 1,750 Medicare Part D prescription drug plans and Medicare Advantage plans with prescription drug coverage have applied to offer lower insulin costs…
Headline
The Government Accountability Office today named three new members to the Medicare Payment Advisory Commission through April 2023. They are: Wayne…
Headline
More than half of U.S. adults aged 70 and older have experienced a disruption in their medical care during the first month of social distancing for COVID-19,…
Headline
The AHA and other national hospital organizations today urged the Department of Health and Human Services and Centers for Medicare & Medicaid Services to…
Headline
The Medicare Hospital Insurance Trust Fund will have sufficient funds to pay full benefits until 2026, according to the latest annual report from the…